Literature DB >> 19125851

Physician or clinical inertia: what is it? Is it really a problem? And what can be done about it?

Marvin Moser.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19125851      PMCID: PMC8673038          DOI: 10.1111/j.1751-7176.2008.00047.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  17 in total

1.  Clarify the Message! Improve Outcome in the Management of Hypertension.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2000-03       Impact factor: 3.738

Review 2.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

3.  Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial.

Authors:  Christianne L Roumie; Tom A Elasy; Robert Greevy; Marie R Griffin; Xulei Liu; William J Stone; Kenneth A Wallston; Robert S Dittus; Vincent Alvarez; Janice Cobb; Theodore Speroff
Journal:  Ann Intern Med       Date:  2006-08-01       Impact factor: 25.391

Review 4.  Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease.

Authors:  P R Hebert; M Moser; J Mayer; R J Glynn; C H Hennekens
Journal:  Arch Intern Med       Date:  1993-03-08

5.  Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.

Authors:  Kwok Leung Ong; Bernard M Y Cheung; Yu Bun Man; Chu Pak Lau; Karen S L Lam
Journal:  Hypertension       Date:  2006-12-11       Impact factor: 10.190

6.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

7.  The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure.

Authors:  Eve A Kerr; Brian J Zikmund-Fisher; Mandi L Klamerus; Usha Subramanian; Mary M Hogan; Timothy P Hofer
Journal:  Ann Intern Med       Date:  2008-05-20       Impact factor: 25.391

8.  Effect of unrelated comorbid conditions on hypertension management.

Authors:  Barbara J Turner; Christopher S Hollenbeak; Mark Weiner; Thomas Ten Have; Simon S K Tang
Journal:  Ann Intern Med       Date:  2008-04-15       Impact factor: 25.391

9.  Treatment of hypertension in patients 80 years of age or older.

Authors:  Nigel S Beckett; Ruth Peters; Astrid E Fletcher; Jan A Staessen; Lisheng Liu; Dan Dumitrascu; Vassil Stoyanovsky; Riitta L Antikainen; Yuri Nikitin; Craig Anderson; Alli Belhani; Françoise Forette; Chakravarthi Rajkumar; Lutgarde Thijs; Winston Banya; Christopher J Bulpitt
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

10.  Lifestyle modifications to lower or control high blood pressure: is advice associated with action? The behavioral risk factor surveillance survey.

Authors:  Anthony J Viera; Abhijit V Kshirsagar; Alan L Hinderliter
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-02       Impact factor: 3.738

View more
  9 in total

1.  Patients' Future Expectations for Diabetes and Hypertension Treatments: "Through the Diet… I Think This is Going to Go Away."

Authors:  Paige C Fairchild; Aviva G Nathan; Michael Quinn; Elbert S Huang; Neda Laiteerapong
Journal:  J Gen Intern Med       Date:  2016-10-11       Impact factor: 5.128

2.  Quality of care in type 2 diabetes in Iran; a cross-sectional study using patient-level data.

Authors:  Majid Davari; Yahya Bayazidi; Abbas Kebriaeezadeh; Alireza Esteghamati; Fatemeh Bandarian; Zahra Kashi; Adele Bahar; Sepideh Yousefi
Journal:  BMC Endocr Disord       Date:  2022-05-17       Impact factor: 3.263

3.  Barriers to blood pressure control: a STITCH substudy.

Authors:  Sigrid A E Nelson; George K Dresser; Margaret K Vandervoort; Cindy J Wong; Brian G Feagan; Jeffrey L Mahon; Ross D Feldman
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12-10       Impact factor: 3.738

4.  The more things change, the more they remain the same.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-04       Impact factor: 3.738

5.  Predicted coronary heart disease risk reduction and dual blood pressure/cholesterol goal attainment in patients with hypertension treated in real-world clinical practice.

Authors:  Joel M Neutel; Michael Eaddy; Orsolya E Lunacsek; Craig Roberts; Linda Chen; Allison J Kean; James H Jackson
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-06       Impact factor: 3.738

6.  Hypertension treatment and control among 28 physician practices across the United States: results of the Hypertension: Assessment of Treatment to Target (HATT) Study.

Authors:  Daniel A Belletti; Christopher Zacker; Jenifer Wogen
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-08       Impact factor: 3.738

7.  Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.

Authors:  S Oparil; S G Chrysant; M Melino; J Lee; S Karki; R Heyrman
Journal:  J Hum Hypertens       Date:  2010-03-04       Impact factor: 3.012

8.  Hypertension treatment practices and its determinants among ambulatory patients: retrospective cohort study in Ethiopia.

Authors:  Derbew Fikadu Berhe; Katja Taxis; Flora M Haaijer-Ruskamp; Afework Mulugeta; Yewondwossen Tadesse Mengistu; Peter G M Mol
Journal:  BMJ Open       Date:  2017-08-03       Impact factor: 2.692

9.  Blood pressure control in hypertensive patients in Irish primary care practices.

Authors:  Brendan Buckley; Eamonn Shanahan; Niall Colwell; Eva Turgonyi; Peter Bramlage; Ivan J Perry
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-08       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.